NURC
NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
06/03/2025
Back to search
Official data from USPTO
AUREGEN BIOTHERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
AUREGEN BIOTHERAPEUTICS
ST13
US500000090609749Class
1, 5, 7, 9, 10, 40, 42, 44
Filing
90609749
Registration
7602926
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
50
Latest update
06/03/2025
Trademark type
Word
Nice classes
1, 5, 7, 9, 10, 40, 42, 44
Filing date
03/29/2021
Registration date
12/17/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/17/2024
Last transaction
06/03/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Geneva, CH
Examiner
SHOOR, AMIT
Current location
Historical data usage
Holders and representatives
Holders
Auregen BioTherapeutics SA
Representatives
LEIGH ANN LINDQUIST SUGHRUE MION, PLLC
Technical classification
Nice Classes
Class 1Class 5Class 7Class 9Class 10Class 40Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Stem cells for research purposes; stem cells for scientific purposes; stem cells for research or scientific purposes; stem cells other than for medical or veterinary purposes; hydrogel polymer edible coatings for tablets; Lactic acid polymers for use in the manufacture of capsules for pharmaceuticals; Aqueous linear polymer gels for use in the manufacture of capsules for pharmaceuticals; Chemical preparations in the nature of photo curable resin compositions comprising polymers for scientific purposes; chemicals for use in polymerisations; engineered biological tissues and tissue arrayshuman and animal organconnectiveepithelialmuscularnervous tissues and tissue arraysfor use in scientific and medical research; biologically compatible materialshydrogels used to create polymeric networks used in the manufacture of living tissue for research and scientific purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment
Class 5
Pharmaceutical preparations for use in the field of 3D bio-printing of tissues and organs for replacing and/or for supporting the function of missing or damaged body parts; Medical preparations based on cellulous nano-fibrils for use in the 3D bio-printing of tissues and organs for medical use; tissue-regenerative pharmaceutical preparations; Biological boneskin tissue intended for subsequent implantation for skin and cartilage; biological skin and cartilage tissue intended for subsequent implantation; cells for medical use; human allograft tissue; living cells for medical use; Surgical implants comprised of living tissues for guided tissue regeneration; implants comprising living tissue; Implants comprised of living tissue for use in guided tissue regeneration; skin grafts; surgical implants comprised of living tissues; surgical implants of living tissues grown from stem cells; transdermal patches for use to create skin for prosthetic limbs and for skin grafts; Implants comprised of living tissues for transplant; antibodies for use to create skin for prosthetic limbs and for skin grafts; stem cells for medical purposes; engineered biological tissues and organshuman and animal cardiovascularpulmonarydigestivehepatobiliaryurologicalrenalendocrineconnectiveepithelialmuscularnervous tissue and organsfor medical purposes; biological molecules to assist in the development of tissue for medical purposes; hemostatic gel matrix preparations for treating wounds; natural biomaterials for augmentation of boneblood and tissue for medical purposes; processed human donor skin for the replacement of soft tissue; pharmaceutical products for tissue regenerationfor tissue repairfor tissue treatmentwhether relating to human or animal tissue; pharmaceutical preparations for the treatment of bone diseasesfor cartilaginous diseasesfor vascular diseasesfor neuronal degenerationfor degeneration of tendons and ligamentsfor retinal degenerationfor renal degenerationdegeneration of soft tissuefor diseases with abnormal cell proliferation; natural biomaterials for bone filling for medical purposes; natural biomaterials for filling cartilage for medical purposes; stem cells for medical use; surgical implants of living tissue; surgical cloths for wound protection; surgical implants grown from stem cells and comprised of living tissue; biological tissue cultures for medical useall the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; Cartridges containing printing material for use with three dimensional printersfilled with natural biomaterials for augmentation of bone and tissue for medical purposes; Cartridges for use with three dimensional printers filled bioprinting material in the nature of living tissue for medical purposes; printing cartridges for use with three dimensional printerscontaining bioink in the nature of living tissue for medical purposes
Class 7
Three-dimensional (3D) printers; three-dimensional (3D) bioprinters; Machines in the nature of computerized equipment for the generation of three-dimensional shaped parts; machines for manufacturing three dimensional modelscomputer-aided modeling devices; machines for manufacturing three dimensional (3D) living tissues; machinesthree dimensional (3D) bioprinter for the printing of living tissues; cartridges for containing printing material for use with three dimensional printerssold empty; cartridges for containing bioprinting material for use with three dimensional printerssold empty; printing cartridges for containing biomaterial for use with three dimensional printerssold empty; printing cartridges for containing bioink for use with three dimensional printerssold empty; 3D printers incorporating an imaging device for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating laboratory apparatus for use in research on biomaterials for the creation of prosthetic limbs and grafts; Combination 3D printers incorporating a scientific research and laboratory apparatus and instruments for research on biomaterials for the creation of prosthetic limbs and grafts in the field of cytology
Class 9
Laboratory apparatus for fabrication of three-dimensional tissues and organs; Biochips for the production of three-dimensional living tissues and organs for research or scientific purposes; bioreactor for cell culturing; bioreactors for laboratory use; bioreactors for research use; cell culture apparatus for laboratory usecell culture dishestissue culture flasks; Nonmedical combination imaging device incorporating a 3D printer for use in research on biomaterials for the creation of prosthetic limbs and grafts; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for use in research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts; print heads for inkjet printers; Scientific research and laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts in the field of cytology; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts for use in biopharmaceutical discovery and development; Laboratory apparatus and instrumentsapparatus and instruments for thermal imagingdetecting pathogensperforming DNA analysisincubatormicroscopefunction generatorsoscilloscopes for research on biomaterialsalso incorporating a 3D printerfor the creation of prosthetic limbs and grafts; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment
Class 10
Dental apparatus and instrumentsincluding imaging devicesfor medical purposesfor use in dental surgery; surgical synthetic modified implants and transplants with endogenous materialtissue cells or molecules made of synthetic materials for replacement and/or for supporting the function of missing or damaged body partsnot for cardiac disease treatment; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; all of the above for synthetic implants
Class 40
3D printing services for others; Custom 3D printing services; renting of 3D printers; creation of customized three-dimensional shaped parts using rapid prototyping equipment; 3D bioprinting for others; Bioprinting for others; Research in the field of three-dimensional (3D) printing in the nature of bioprinting for others; Technical consultancy in the field of rapid prototype fabrication of new products for others
Class 42
Technical research in the fields of biomimeticsbiomaterialsmaterial adaptation3D bioprinting and tissue engineering; research and development of medical devices; research in the field of nanotechnology and nanomaterials; synthetic biology research; robotics research; bioengineering research; nanotherapeutics research; Biological research in the field of three-dimensional (3D) bioprinting; tissue engineering research; research and development of 3D technology and processes; development of rapid prototyping equipment; scientific research consulting in the fields of three-dimensional printing; scientific services relating to the isolation and cultivation of human tissues and cells; scientific and medical research and development in the field of bio-printing; scientific and medical research and development in the field of tissue manufacturing; Tissue engineering in the nature of development and culture of artificial tissues and cells; Tissue engineering services in the nature of development and culture of artificial tissues and cells for scientific and research purposes; Scientific and medical research and analysis services in the field of tissue engineering researchregenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; Scientific research and material testing services in the fields of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; research and development of new products for others in the fields of regenerative biotherapiesgenomicsbiotechnologychemicals and pharmaceuticals; Autologous and allogeneic tissue engineering in the nature of development and culture of artificial tissues and cells for scientific and research purposes; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment
Class 44
Medical servicesin the field of gene and cellular immunotherapies and transplantation; Medical diagnostic monitoring and reporting of testing services; human cell and tissue banking services; collection and preservation of human blood and cells for medical use; all the aforementioned for in vivo use in the fields of therapeutic and/or aesthetic treatment; medical treatment services; consulting services in the fields of medical treatment and medicines; medical servicesplastic surgery and microsurgeryin particular reshaping noses (rhinoplasty) for either cosmetic or reconstructive purposes
Publications
History of USPTO decisions and trademark events.
50 publications found
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
05/15/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/06/2025
ES7R
TEAS SECTION 7 REQUEST RECEIVED
12/19/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/17/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
12/17/2024
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
07/03/2024
IUCN
NOTICE OF ALLOWANCE CANCELLED
07/03/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
06/20/2024
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
02/20/2024
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/20/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/26/2023
PUBO
PUBLISHED FOR OPPOSITION
12/26/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/06/2023
EXPT
EXPARTE APPEAL TERMINATED
11/20/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/20/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/18/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/18/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/18/2023
JURT
JURISDICTION RESTORED TO EXAMINING ATTORNEY
10/18/2023
EXAF
EXPARTE APPEAL RECEIVED AT TTAB
10/18/2023
GNS1
NOTIFICATION OF SUBSEQUENT FINAL EMAILED
07/19/2023
GNSF
SUBSEQUENT FINAL EMAILED
07/19/2023
CFRC
SUBSEQUENT FINAL REFUSAL WRITTEN
07/19/2023
DOCK
ASSIGNED TO EXAMINER
06/12/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
04/03/2023
ALIE
ASSIGNED TO LIE
04/01/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/24/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/13/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/13/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/13/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/13/2022
GNRT
NON-FINAL ACTION E-MAILED
09/13/2022
CNRT
NON-FINAL ACTION WRITTEN
09/13/2022
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
07/07/2022
GNFR
FINAL REFUSAL E-MAILED
07/07/2022
CNFR
FINAL REFUSAL WRITTEN
07/07/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
05/18/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
05/18/2022
ALIE
ASSIGNED TO LIE
05/16/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/10/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/10/2021
GNRT
NON-FINAL ACTION E-MAILED
11/10/2021
CNRT
NON-FINAL ACTION WRITTEN
11/10/2021
DOCK
ASSIGNED TO EXAMINER
11/08/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
08/11/2021
ALIE
ASSIGNED TO LIE
08/11/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
08/06/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/04/2021
NWAP
NEW APPLICATION ENTERED
04/01/2021
Continuous trademark protection
Get notified about every new filing that threatens AUREGEN BIOTHERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.